NXPL
NextPlat Corp
+0.22 (+2.55%)9.05USD7.1K成交股數24.5M市值–本益比(近四季)0.5股價營收比-10.3%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 11.9M-10% | 9.9M-29% | 13.4M-13% | 13.8M-19% | 13.2M-24% | 13.9M-16% | 15.4M+1% | 17.0M+475% | 17.5M | 16.6M | 15.3M | 3.0M |
| 營業成本 | 7.2M | 6.4M | 11.0M | 11.0M | 10.4M | 11.1M | 11.8M | 11.1M | 12.6M | 11.4M | 10.7M | 2.1M |
| 毛利 | 4.7M+63% | 3.4M+19% | 2.4M-32% | 2.7M-53% | 2.9M-41% | 2.9M-46% | 3.6M-22% | 5.9M+594% | 4.9M | 5.3M | 4.6M | 844K |
| 毛利率 | 39.5% | 34.6% | 18.1% | 19.9% | 21.8% | 20.6% | 23.2% | 34.5% | 27.8% | 31.6% | 30.0% | 28.5% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 2.4M | 2.0M | 520K | 1.5M | 2.0M | 2.0M | 1.7M | 1.6M | 1.4M | 2.4M | 4.2M | 2.5M |
| 營業利益 | −127K-93% | −1.1M-47% | −3.1M-61% | −2.0M-82% | −1.8M-1% | −2.1M-86% | −8.0M+130% | −10.9M+225% | −1.8M | −15.2M | −3.5M | −3.4M |
| 營業利益率 | -1.1% | -11.2% | -23.1% | -14.5% | -13.8% | -15.0% | -52.1% | -64.1% | -10.5% | -91.1% | -22.7% | -113.5% |
| 稅後淨利 | −144K-92% | −1.1M-42% | 5.9M-240% | −2.2M-59% | −1.8M+21% | −1.9M-194% | −4.2M-222% | −5.3M+22% | −1.5M | 2.1M | 3.4M | −4.3M |
| 淨利率 | -1.2% | -11.3% | 44.1% | -15.9% | -13.5% | -13.9% | -27.4% | -31.3% | -8.5% | 12.4% | 22.6% | -146.8% |
| 稀釋 EPS | – | – | – | – | – | -0.05-29% | -0.22-229% | – | -0.08 | -0.07 | 0.17 | -0.24 |
| 稀釋股數 | 2.7M | 2.7M | 26.5M | 26.0M | 2.6M | 2.6M | 19.0M | 18.8M | 18.7M | 17.5M | 20.3M | 18.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.9M | 11.0M | 13.7M | 13.9M | 16.6M | 17.7M | 20.4M | 24.9M | 23.5M | 26.3M | 26.3M | 20.6M |
| 應收帳款 | 8.2M | 7.2M | 5.9M | 4.0M | 3.2M | 5.5M | 6.6M | 10.4M | 12.9M | 8.9M | 7.8M | 589K |
| 存貨 | 4.1M | 4.0M | 3.4M | 5.6M | 5.2M | 4.5M | 6.4M | 4.7M | 5.6M | 5.1M | 5.0M | 2.1M |
| 總資產 | 28.7M | 26.9M | 27.5M | 30.0M | 31.0M | 35.2M | 41.1M | 51.5M | 65.1M | 64.5M | 66.2M | 30.9M |
| 有息負債 | 1.0M | 1.2M | 1.3M | 1.2M | 1.2M | 1.3M | 1.5M | 1.3M | 1.4M | 1.5M | 1.6M | – |
| 總負債 | 12.2M | 10.3M | 10.0M | 8.5M | 7.4M | 9.8M | 11.3M | 14.5M | 18.0M | 16.4M | 16.7M | 2.5M |
| 股東權益 | 16.4M | 16.5M | 17.3M | 21.4M | 23.5M | 25.3M | 22.5M | 26.5M | 31.2M | 32.2M | 33.2M | 28.4M |
| 負債比 | 42.5% | 38.4% | 36.6% | 28.2% | 23.9% | 27.7% | 27.5% | 28.2% | 27.6% | 25.4% | 25.2% | 8.1% |
| 淨現金(現金 − 有息負債) | 10.9M | 9.9M | 12.4M | 12.8M | 15.5M | 16.5M | 18.8M | 23.6M | 22.1M | 24.8M | 24.7M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.6M+25% | – | – | – | −2.1M | – | – | −2.7M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 22K | – | – | 64K | – | – | – |
| 自由現金流 | – | −2.6M+24% | – | – | – | −2.1M | – | – | −2.7M | – | – | – |
| 折舊攤銷 | – | – | – | 130K | 150K | – | 478K | 903K | 906K | 909K | 871K | 168K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -26.2% | – | – | – | -14.9% | – | – | -15.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 68.9M
| Healthcare Operations | 39.7M | 57.6% | -24.1% |
|---|---|---|---|
| Ecommerce | 14.6M | 21.2% | +5.9% |
| Ecommerce Revenue | 14.6M | 21.2% | +5.9% |
產品／服務2025 年度 · 59.0M
| Pharmacy Prescription And Other Revenue Net Of Pbm Fees | 35.7M | 60.5% | -14.8% |
|---|---|---|---|
| Ecommerce Revenue | 14.6M | 24.8% | +5.9% |
| 服務 | 4.7M | 7.9% | -55.8% |
| Pharmacy340b Contract | 4.0M | 6.8% | -61.4% |
| 產品 小計 | 49.7M | 84.2% | -10.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 54.3M | -17.8% | −10K | -0.0% | -0.44 | −6.2M |
| FY2024 | 66.1M | +75.0% | −23K | -0.0% | -0.65 | −5.7M |
| FY2023 | 37.8M | +222.4% | −12K | -0.0% | -0.22 | −4.2M |
| FY2022 | 11.7M | +51.3% | −9.2M | -78.2% | -0.96 | −4.3M |
| FY2021 | 7.7M | +36.0% | −8.1M | -104.8% | -1.98 | −4.3M |
| FY2020 | 5.7M | -3.1% | −2.8M | -48.6% | -132.05 | −872K |
| FY2019 | 5.9M | +2.5% | −1.4M | -23.5% | -13.00 | −729K |
| FY2018 | 5.7M | – | −1.2M | -20.9% | -19.14 | −621K |